, Columnist
The Real Vaccine Crisis Isn’t About J&J or AstraZeneca
One of the most serious Covid-era challenges the world will face is the unequal distribution of vaccines between rich and poor countries.
Poor countries deserve a shot.
Photographer: Veejay Villafranca/BloombergThis article is for subscribers only.
To judge by the headlines, you’d think the most critical immunization issue facing the world is the safety and hesitancy concerns over the AstraZeneca Plc and Johnson & Johnson vaccines.
That debate is genuinely important. Still, it shouldn’t distract from the biggest challenge the world will face over the coming months: the grossly unequal distribution of vaccines between rich and poor countries.